Say something
Lupin Ltd announced that its unit has received US FDA approval for Imipramine Pamoate capsules, an abbreviated new drug application (ANDA). The capsules are the generic equivalent of Mallinckrodt’s Tofranil-PM. The capsules had sales of about USD 39 million in the year 2009 in the US market.
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
The Indian government is concentrating on producing high-end medical devices and pharmaceuticals as part of its effort t...
The Drugs Controller General of India, Dr. V. G. Somani said on Friday that the center is getting ready to launch a rese...
Punjab Bureau of Investment Promotion (PBIP) has orgainsed a One-day Outreach & Consultation Workshop on bridging th...
Doceree,a global platform building unprecedented solutions for HCP programmatic marketing with proprietary data tools, t...
Drugs Controller General of India (DCGI) authorized the emergency use of two Covid-19 vaccines for children under the ag...
HealthPlix Technologies, a SaaS platform for doctors, released the mobile version of its AI-powered EMR. Available on al...
CLIRNET, a Live Digital CME & Doctor Generated Medical Content Platform, has announced the launch of Doctor’s Voic...
Doceree, the first global network of physician-only platforms for programmatic messaging, today announced the completion...
Aiming at providing protection cover to children in the age group of 15-18, Uttar Pradesh has so far administered vaccin...
Union Health Minister Mansukh Mandaviya has informed that the Covid-19 vaccination for 12-14-year-olds and 'precaution d...
